Login / Signup

Use of Pre-Infusion Serum Uric Acid Levels as a Biomarker for Infusion Reaction Risk in Patients on Pegloticase.

Robert T KeenanHerbert S B BarafBrian LaMoreaux
Published in: Rheumatology and therapy (2019)
Horizon Pharma.
Keyphrases
  • uric acid
  • end stage renal disease
  • metabolic syndrome
  • low dose
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • patient reported outcomes
  • patient reported